'Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions’ — ‘COLOSSUS’
Moleculaire analyse van celvrij circulerend DNA (cfDNA) en/of circulerende tumorcellen (CTC) als 'liquid biopsy' voor de evaluatie van predictieve biomerkers in gemetastaseerde colorectale tumorpatiënten (mCRC).
Pathways betrokken in ZEB1-gemedieerde EMT als doelwit voor de behandeling van een aggressieve vorm van colorectale kanker.
Aryl-hydrocarbon receptor-interacting protein regulates tumorigenic and metastatic properties of colorectal cancer cells driving liver metastasis
Spatial Proteomic Analysis of Isogenic Metastatic Colorectal Cancer Cells Reveals Key Dysregulated Proteins Associated with Lymph Node, Liver, and Lung Metastasis
Gevokizumab, an interleukin-1β (IL-1β) monoclonal antibody (mAb), in metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer (mGEC) and metastatic renal cell carcinoma (mRCC): "first-in-cancer" phase Ib study.
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009
Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Databa
Targeting quorum-sensing peptides for diagnosis, treatment and/or prevention of colorectal cancer metastasis